Comparison Chart Recursion Pharmaceuticals, Inc.
Stocks
RXRX
US75629V1044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 3.740 USD | -3.86% |
|
-2.35% | -8.56% |
| 09-21 | Recursion Pharmaceuticals, Inc. Grants Tempus Ai, Inc. Non-Exclusive License for Rna Foundation Model | CI |
| 09-21 | Tempus AI, Recursion Extend Data License, Amend Fee Structure | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -3.86% | -2.35% | -8.56% | -20.76% | -84.75% | 2.01B |  | |  |
- Stock Market
- Stocks
- RXRX Stock
- Charts Recursion Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
